ArticleJBMR plus2019

Cost-Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate-Alone Strategies in High-Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide.

Takahiro Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.